🇺🇸 FDA
Patent

US 10512667

Compositions and methods for treating conditions related to adrenocortical activity and/or excessive steroid production

granted A61KA61K2300/00A61K31/17

Quick answer

US patent 10512667 (Compositions and methods for treating conditions related to adrenocortical activity and/or excessive steroid production) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K2300/00, A61K31/17, A61K31/18, A61K31/277